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Background: Circulating neurohormones reflect cardiac pressure and volume overload and their baseline levels provide predictive information in 
heart failure (HF) patients. We hypothesized that their predictive value may be further enhanced by cardiopulmonary exercise (CPX).
Methods: We measured plasma levels of the mid-regional pro-atrial natriuretic peptide (MR-proANP), MR-proadrenomedullin (MR-proADM) and 
copeptin (all BRAHMS) and of NT-proBNP (Roche) in 108 advanced HF patients (NYHA average 2.73±0.60, 47% ischemic, age 53.7±8.4) undergoing 
symptom-limited CPX stress testing. Blood samples were collected before and immediately after CPX. We used Cox proportional hazard models to 
examine the association between biomarker levels and adverse outcomes (death, urgent heart transplant or VAD implantation).
Results: The average follow-up was 17.0±9.8 months. After adjustment for important clinical covariates, the most predictive baseline tests were 
MR-proADM (HR 3.74, 95% CI 1.49-9.41, p=0.005) and MR-proANP (3.21, 1.31-7.84, 0.01). With the exception of MR-proADM, predictive value 
of the other three markers increased after CPX. MR-proANP was associated with highest HR (4.82, 1.52-15.28, 0.007), followed by copeptin (3.74, 
1.46-9.59, 0.006). Baseline MR-proANP and post-CPX copeptin was the most informative combination of pre- and post-CPX tests (Figure 1).
Conclusions: Measurement after CPX testing enhances prognostic value of neurohormonal biomarkers in patients with HF.
 
